Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

784
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
784
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

769
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
769
Relative Risk01:12

Relative Risk

2.3K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.3K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

5.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.3K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

1.1K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.1K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

713
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
713

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Telemedicine Use and Access to Care for New Patients at an Academic Cardiovascular Center: An Analysis of Geographic Reach and Wait Times.

Journal of the American Heart Association·2026
Same author

Hypoglycaemia care: Time to modernise our treatment standards.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same author

Hypoglycaemia Was Not Associated With Depression, Anxiety, Diabetes Distress or Fear of Hypoglycaemia Scores in People With Type 1 or Insulin-Treated Type 2 Diabetes in the Hypo-METRICS Study.

Diabetes, obesity & metabolism·2026
Same author

Real-World Evidence Assessment of the Risk of Nonfatal Stroke in Patients Prescribed SGLT2 Inhibitors.

Stroke research and treatment·2026
Same author

Automated Insulin Delivery Use Among Preschool-Age Children With Type 1 Diabetes: A T1D Exchange Multicenter Analysis.

Journal of diabetes science and technology·2026
Same author

Gender differences in hypoglycaemia in type 1 and insulin-treated type 2 diabetes: the Hypo-METRICS study.

Diabetologia·2026

相关实验视频

Updated: Mar 9, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

1.1K

将血糖危险指数纳入临床实践和研究:一个共识报告

Guillermo E Umpierrez1, Viral N Shah2, Veronica Brady3,4

  • 1Emory University School of Medicine, Atlanta, GA, USA.

Journal of diabetes science and technology
|March 7, 2026
PubMed
概括
此摘要是机器生成的。

新的血糖风险指数 (GRI) 提供了一个单一的指标来评估持续血糖监测 (CGM) 数据的血糖控制质量. 专家建议将其集成到CGM平台中,以改善糖尿病管理和研究.

关键词:
这是一个复合材料.不断监测葡萄糖的情况.数据平台的数据平台.数据可视化数据可视化葡萄糖血症风险指数指数在时间范围内的时间范围.

更多相关视频

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
06:13

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health

Published on: December 1, 2023

1.8K
Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K

相关实验视频

Last Updated: Mar 9, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

1.1K
Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
06:13

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health

Published on: December 1, 2023

1.8K
Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K

科学领域:

  • 内分泌学 在内分泌学.
  • 生物医学信息学 生物医学信息学
  • 数据科学数据科学数据科学

背景情况:

  • 持续葡萄糖监测 (CGM) 提供了关于葡萄糖水平的广泛数据.
  • 像 ambulatory glucose profile (agp) 这样的现有指标提供了洞察力,但缺乏单一的综合评分.
  • 需要一个标准化的指标来评估从CGM数据的整体血糖控制质量.

研究的目的:

  • 讨论血糖风险指数 (GRI) 对临床护理,研究和人口健康管理的有用性.
  • 介绍GRI指标的数学推导和应用.
  • 引入GRI计算器智能手机应用程序及其在评估CGM数据中的作用.

主要方法:

  • 一个专家小组召开讨论GRI,一个由AGP的七个组成部分衍生的复合度量.
  • 介绍了GRI的数学基础.
  • 展示了GRI计算器应用程序用于计算GRI和可视化CGM跟踪.

主要成果:

  • 该GRI提供了一个单一的百分比得分 (0-100,更低更好),反映了14天内的血糖质量.
  • 在特定情况下,GRI的实用性得到证明,包括糖尿病和癌症患者服用影响葡萄糖的药物.
  • 该GRI作为AI模型评估血糖质量的基准,并集成到iCoDE-2项目中.

结论:

  • 专家小组一致建议将GRI纳入用于胰岛素使用者的CGM数据平台.
  • 需要进一步的研究来探索GRI对非胰岛素使用者的价值.
  • GRI增强了对CGM数据的解释,帮助临床护理,研究和AI模型开发.